Overview
My research program is focused on transforming the prevention and management of bleeding and thrombosis in critically ill children through precision transfusion medicine. Despite the widespread use of platelet transfusions in pediatric critical care, clinicians currently lack both evidence-based transfusion thresholds and biologically meaningful markers of platelet function to guide treatment decisions. As a result, platelet transfusions are frequently administered based on platelet count alone, despite growing evidence that transfusions may contribute to thrombosis, bleeding, organ dysfunction, and mortality.
To address these critical gaps, my research program integrates mechanistic discovery science with multicenter clinical trials to improve outcomes for children at high risk of bleeding. My work has included the study of platelet lipidomics in critical illness, the development and validation of definitions of bleeding specific to critically ill children and the development of evidence-based guidelines for the transfusion of platelets and plasma in the pediatric intensive care unit.
My research has focused on populations of children who frequently receive platelet transfusions - those supported by extracorporeal membrane oxygenation (ECMO), children following cardiopulmonary bypass surgery and children with oncologic diagnoses.
Highlights
- 1Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2022
- 2
- 3Critical care medicine · 2025
Publications
Funding
Active
3 grants- Sub-PIR01HD106326-04Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill childrenEunice Kennedy Shriver National Institute of Child Health and Human Development · 2021–2027 · via Yale University
- Sub-PIR01HL157208-05Transfusion and Organ Dysfunction in Pediatric Septic Shock (TROPICS) studyNational Heart, Lung, and Blood Institute · 2022–2027 · via Research Institute at Nationwide Chidren'sHospital
- MPIR34HL159119-03ECmo hemoSTAtic Transfusions In Children (ECSTATIC)National Heart, Lung, and Blood Institute · 2022–2026 · via Yale University· 2 renewals
Completed grants (4)
- PIR13HL154544-01TAXI-CAB: Transfusion and Anemia eXpert Initiative - Control/Avoidance of BleedingNational Heart, Lung, and Blood Institute · 2020–2022
- Sub-PIR01HS092471-03Ancillary to ABC PICU to Study MOD in Critically Ill ChildrenEunice Kennedy Shriver National Institute of Child Health and Human Development · 2017–2022 · via University of California, Los AngelesNo publications yet
- Sub-PIR21HD089131-02Prevention of central venous catheter-associated thrombosis in critically ill childrenEunice Kennedy Shriver National Institute of Child Health and Human Development · 2019–2019 · via Yale University
- MPIU01HL116383-05Age of Blood in Children in Pediatric Intensive Care Units (ABC-PICU)National Heart, Lung, and Blood Institute · 2014–2019 · via University of Washington, The
Clinical research
Active
3 studies- PIPlatelet Dysfunction and the Role of Platelet Transfusion in Extracorporeal Membrane Oxygenation (ECMO) - An -Omics ApproachWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
- PITRansfusion and Organ Dysfunction in PediatrIC Septic shock (TROPICS)Nationwide Children's Hospital · OPEN TO ACCRUAL (as of 2022)
- PINCT04924322Age-dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-associated Thrombosis in Critically Ill ChildrenPHASE2; PHASE3 · Yale University · OPEN TO ACCRUAL (as of 2022)Deep Venous Thrombosis
Completed & closed trials (4)
- PINCT05796557ECMO Hemostatic Transfusions in ChildrenPHASE4 · Yale University · IRB STUDY CLOSURE (as of 2025)Extracorporeal Membrane Oxygenation Complication; Hemorrhage; Thromboembolism; Transfusion Adverse Reaction
- PICurrent Practices in Pediatric Intensive Care Units to Improve Patient Mental Health Outcomes: A SurveyWeill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2025)
- PINCT05293106Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical TrialPHASE4 · Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2024)Cardiopulmonary Bypass Surgery
- PIBlood Utilization Among COVID-19 Hospitalized Patients in New York City: An INSPIRE Database StudyWeill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2021)
Datasets
- nct05796557ECMO Hemostatic Transfusions in ChildrenClinicalTrials.gov · PHASE4 · COMPLETED · registration (not microdata) · 2024 · Open access
Mentoring
- ELEmily LangMD mentee · Class of 2022
- KFKimberly ForlenzaMD mentee · Class of 2021
- BSBrandon SumidaMD mentee · Class of 2019